Status:
COMPLETED
"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19
Lead Sponsor:
FMH College of Medicine and Dentistry
Conditions:
COVID-19 Pneumonia
Eligibility:
All Genders
16-85 years
Brief Summary
COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in...
Detailed Description
Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hos...
Eligibility Criteria
Inclusion
- Critically sick patients with COVID-19 Pneumonia
- All admitted ICU patients with a diagnosis of COVID-19 pneumonia
- Patients having positive reverse transcriptase PCR for COVID-19
- Patients with High-resolution computed tomography (HRCT) chest findings suggestive of COVID-related lung injury
- All patients above 16 years of age with both genders( males and females)
Exclusion
- All patients with PCR negative with mild symptoms
- Patients with No signs of COVID-19 pneumonia on HRCT chest
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT05249803
Start Date
March 1 2021
End Date
December 31 2021
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fatima Memorial Hospital College of Medicine & Dentistry
Lahore, Punjab Province, Pakistan, 54000